Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry

被引:65
作者
Jia, Lewen [1 ,2 ]
Chen, Jing [1 ]
Yin, Peiyuan [1 ]
Lu, Xin [1 ]
Xu, Guowang [1 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&A Ctr, Dalian 116023, Peoples R China
[2] Dalian Univ Med, Affiliated Hosp 1, Dept Nephrol, Dalian 116011, Peoples R China
基金
中国国家自然科学基金;
关键词
metabonomics; UPLC; Q TOF MS; chronic renal failure; biomarker;
D O I
10.1007/s11306-008-0110-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A metabonomics technique based on ultra-performance liquid chromatography (UPLC) coupled with Q-TOF mass spectrometry was employed to investigate the sera from 32 patients with chronic renal failure (CRF) without renal replacement therapy and 30 healthy volunteers in order to find potential disease biomarkers and reveal its pathophysiological changes. After data acquisition Waters MarkerLynx software was used to report retention time and m/z pairs for each metabolite peak, these data were exported to an excel table, then handled by using multivariate analysis and the statistical analysis in the SIMCA-P and the SPSS softwares to obtain potential biomarkers which were further identified by MS/MS. Seven potential biomarkers, creatinine, tryptophan, phenylalanine, kynurenine and three lysophosphatidylcholines, were identified. The results suggest that CRF can lead to the increase of reservation of creatinine in the body, and the abnormal metabolism of the two essential amino acids and lysophosphatidylcholines. It has indicated that metabonomics will be a powerful tool in the clinic research.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 37 条
[31]   Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling [J].
Want, Elizabeth J. ;
Smith, Colin A. ;
Qin, Chuan ;
VanHorne, K. C. ;
Siuzdak, Gary .
METABOLOMICS, 2006, 2 (03) :145-154
[32]   High resolution "Ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies [J].
Wilson, ID ;
Nicholson, JK ;
Castro-Perez, J ;
Granger, JH ;
Johnson, KA ;
Smith, BW ;
Plumb, RS .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (02) :591-598
[33]  
Xu Yan, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P23, DOI 10.2174/1568008033340414
[34]  
Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753
[35]   High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B [J].
Yang, J ;
Zhao, XJ ;
Liu, XL ;
Wang, C ;
Gao, P ;
Wang, JS ;
Li, LJ ;
Gu, JR ;
Yang, SL ;
Xu, GW .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (03) :554-561
[36]   Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS) [J].
Yin, Peiyuan ;
Zhao, Xinjie ;
Li, Qiurong ;
Wang, Jiangshan ;
Li, Jieshou ;
Xu, Guowang .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (09) :2135-2143
[37]   Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective [J].
Zoccali, C. .
KIDNEY INTERNATIONAL, 2006, 70 (01) :26-33